Prescription Monitoring Programs: An Update on Interstate Data Sharing

Similar documents
State of California Department of Justice. Bureau of Narcotic Enforcement

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)

DEA: Combating the Supply

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Retaking NPTE

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Direct Access

2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI

Overview and Findings from ASTHO s IIS Interstate Data Sharing Meeting

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Direct Access

Workforce Data The American Board of Pediatrics

RECOVERY SUPPORT SERVICES IN STATES

A National and Statewide Perspective on the Opioid Crisis

Application of Advanced Practice Nurses Attitudes and Behaviors about Opioid Prescribing for Chronic Pain Survey

AMERICAN IMMUNIZATION REGISTRY ASSOCIATION A L I S O N C H I, P R O G R A M D I R E C T O R

USA National Mental Healthcare Nonprofit Exempt Organization Financial Analysis as of December 14, 2015 January 24, 2016 ANSA-H2

Evidence-Based Policymaking: Investing in Programs that Work

Financial Impact of Lung Cancer in West Virginia

2016 COMMUNITY SURVEY

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Foreign Educated Physical Therapists

The Affordable Care Act and HIV: What are the Implications?

Legal and Policy Approaches to Reducing Prescription Drug Overdose

EDIBLE CANNABIS STATE REGULATIONS. Karmen Hanson, MA- Health Program

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: License Renewal. License Renewal on Birthdays

The Changing Face of Heroin Use in the US: A Retrospective Analysis of the Past 50 Years 100 Heroin 90 Prescription opioids

THREE BIG IMPACT ISSUES

Hawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals Quest Diagnostics Drug Testing Index

BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Direct Access

Who is paying pharmacists? Network inclusion Standard and simplified processes

State Tobacco Control Programs

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Foreign Educated PTs and PTAs

How to Get Paid for Doing EBD

Legal & Policy Approaches to Reducing Prescription Drug Overdose

THE STATE OF THE STATES MARIJUANA POLICIES: STATE MARIJUANA PROGRAMS & RELATED STATE LAWS OVERVIEW

Marijuana and driving in the United States: prevalence, risks, and laws

Expedited Partner Therapy (EPT)/Patient Deliver Partner Therapy (PDPT)

MEDICAID FINANCING OF HPV VACCINE: Access for Low-Income Women

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper

Overview of the States Pesticide Registration Process AAPCO Laboratory Committee

Voluntary Mental Health Treatment Laws for Minors & Length of Inpatient Stay. Tori Lallemont MPH Thesis: Maternal & Child Health June 6, 2007

Authorities, Organization, & Key Issues Concerning Federal, State, & Local Public Health Laws

Black Women s Access to Health Insurance

Alzheimer s Association Clinical Studies Initiative

Program Overview. Karen L. Swartz, M.D. Johns Hopkins University School of Medicine

Maternal and Child Health Initiatives in Sickle Cell Disease

The drug 3,4-methylenedioxymethamphetamine

Women s Health Coverage: Stalled Progress

AMERICA S OPIOID EPIDEMIC AND ITS EFFECT ON THE NATION S COMMERCIALLY-INSURED POPULATION PUBLISHED JUNE 29, 2017

Addressing Challenges Together, One Rock at a Time

Improving Oral Health:

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioids And DEA Compliance

Ms. Tramaine Stevenson Director of Program Development and Operations National Council for Behavioral Health

ANNUAL REPORT EXECUTIVE SUMMARY. The full report is available at DECEMBER 2017

Strategies to Increase Hepatitis C Treatment Within ADAPs

POLICY BRIEF. State Variability in Access to Hospital-Based Obstetric Services in Rural U.S. Counties. April rhrc.umn.edu. Purpose.

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Overview of the HHS National Network of Quitlines Initiative

SNAP Outreach within Food Banks: A View From The Ground

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Improving Access to Oral Health Care for Vulnerable and Underserved Populations

LaTanya Runnells, Ph.D Program Manager December 6, 2016

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

Tuberculosis and Travel

Report to Congressional Defense Committees

OREGON MEDICAL MARIJUANA PROGRAM STATISTICAL SNAPSHOT JANUARY, 2015 (REVISED 02/26/2015)

Prescription Opioid Overdose in Oregon: A public health perspective

WORKERS COMPENSATION AND PRESCRIPTION DRUGS: 2016 Update

Prescription Monitoring Programs - Legislative Trends and Model Law Revision

Approach to Cancer Prevention through Policy, Systems, and Environmental Change in the U.S.

a call to states: make alzheimer s a policy priority

Expanding Immunizing Pharmacist Services in North Carolina

ADEA Survey of Dental School Seniors, 2015 Graduating Class Tables Report

Radiation Therapy Staffing and Workplace Survey 2016

CONGRESSIONAL BRIEFING. PRESCRIPTION DRUG MONITORING PROGRAMS (PDMPs): CRITICAL DECISION SUPPORT TOOLS TO RESPOND TO THE OPIOID CRISIS

Social Host Liability: Preventing Underage Drinking Parties James F. Mosher, JD Alcohol Policy Consultations March 6, 2012

Emerging Issues in Cancer Prevention and Control

Integrated HIV Statewide Coordinated Statement of Need (SCSN)/Comprehensive Plan Update

Drug Overdose Deaths in the United States,

Prescription Drug Monitoring Program

CDC s National Comprehensive Cancer Control Program (NCCCP): 2010 Priorities and New Program Opportunities

Improving Cancer Surveillance and Mortality Data for AI/AN Populations

East Regional PMP. PMP Center of Excellence Update. Baltimore, MD April 6, 2011

SASI Analysis of Funds Distributed in the United States By the Centers for Disease Control and Prevention (CDC) Pursuant to PS

Mark W. Caverly, Chief Liaison and Policy Section

The Right Hit. DEVELOPING EFFECTIVE MEDIA STRATEGY AT SYRINGE SERVICES PROGRAMS

Mental Health First Aid USA

Dental ER Visits: Evidence of a Failed System. Shelly Gehshan AACDP Conference April 29, 2012

Expanding Contraceptive Access: Developing and Implementing State-based Approaches March 16, Co-sponsored by:

African American Women and HIV/AIDS: Confronting the Crisis and Planning for Action

Addressing the Substance Abuse Needs of Army National Guard Service Members

What is the Objective of the DQA in Developing Performance Measures. Robert Compton, DDS Executive Director

UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, D.C

Mexico. April August 2009: first wave

Neuropsychological Evaluations of Capacity STEVEN E. ROTHKE, PH.D., ABPP HAYLEY AMSBAUGH, M.S.

The Crazy World of

CHILDHOOD ALLERGIES IN AMERICA

Shu-Hong Zhu, PhD University of California, San Diego INTRODUCING THE ASIAN SMOKERS QUITLINE (ASQ)

Transcription:

Prescription Monitoring Programs: An Update on Interstate Data Sharing National Conference of State Legislatures July 28, 2010 David R. Hopkins Kentucky Cabinet for Health and Family Services Office of Inspector General

The Scope of the Problem in Kentucky 8.5% of Kentuckians used prescription psychotherapeutic drugs for non-medical reasons in past year. (KY leads nation) 7% of Kentuckians have used prescription pain relievers such as Darvon and Percodan for non- medical reasons in past year. (KY leads nation). 4.6% of Kentuckians have used prescription tranquilizers such as such as Valium and Xanax for non-medical reasons in past year. (KY leads nation) 2.0% of Kentuckians have used prescription stimulants for non-medical reasons in past year (KY fourth in nation) Source: Misuse of Prescription Drugs: Data from the 2002, 2003 and 2004 National Surveys on Drug Use and Health, published by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, September 2006.

Prescription Monitoring Programs (PMPs)

Purpose of a PMP PMPs are intended to help prevent the abuse and diversion of controlled pharmaceutical substances In a manner that does not impede use for legitimate medical purposes! PMPs provide a tool for prescribers and dispensers to identify and prevent misuse, abuse and doctor shopping PMPs provide an investigative tool for law enforcement to inhibit and prevent diversion

PMP Operation PMPs track controlled substances as reported by dispensers Schedules II through V as determined by each state t Data typically available to: Practitioners for medical treatment t t of a patient t Pharmacists for pharmaceutical treatment of a patient Law enforcement officers for an open drug investigation

Controlled Substance Schedules Schedule I Illegal Drugs e.g. heroin, marijuana, etc. Schedule II Most addictive legal drugs; high abuse potential e.g. oxycodone (OxyContin, Percocet, Tylox). Schedule III Less abuse potential than I or II e.g. hydrocodone combinations (Vicodin, Lortab). e.g. hydrocodone combinations (Vicodin, Lortab). Schedule IV Less abuse potential than III e.g. benzodiazepines (Xanax, Valium). Schedule V least abuse potential e.g. codeine containing cough mixtures.

States with PMPs States with Monitoring Programs WA OR NV CA AK MT ID WY UT CO AZ NM HI ME ND V MN T N H SD WI NY MI NE IA PA N J IL IN OH W V VA KS MO KY OK TN NC AR SC MS AL GA LA PR TX FL C-II only C-II, III C-II, III, IV C-II, III, IV,V VV RI DE MD DC

States with PMP Legislation States with Monitoring Programs WA OR NV CA GU ME MT ND V MN T N H ID SD WI NY WY MI PA NE IA N J IL IN OH UT W CO V VA KS MO KY TN NC AZ NM OK AR SC MS AL GA LA PR TX FL AK HI RI DE MD DC

The Need for Sharing Prescription Monitoring Program Data

Why Share Data? Abusers/diverters not constrained by state borders PMP users requesting to see data from additional states Controlled substances dispensed within a state prescribed throughout the country

Rx s Dispensed in KY by State of Origin 1,179 73

Current PMP Data Sharing Kentucky and many state PMPs allow authorized users from other states and federal agencies. Users must maintain i PMP accounts with multiple states Multiple userids Multiple passwords States do not currently have formal agreements to share data

The Prescription Monitoring Information Exchange Project (PMIX)

Why PMIX? 50+ State / territory programs States have different problems, resources and approaches States have proven track record for collecting and providing data Implement a national-level PMP data Implement a national level PMP data sharing solution with state-level control

PMIX Project Sponsorship U.S. Bureau of Justice Assistance Project Management by IJIS Institute Project direction by BJA/IJIS PMP Committee (representatives from state PMPs, technology vendors, federal and national partners

PMIX Primary Goal Implement a standardized, secure, scalable approach for the exchange of electronic PMP data among states Utilize PMIX Hub to provide focal point for common design and execution

Kentucky PMP authorized User PMIX Flow Indiana PMP System ` Kentucky PMP System Ohio PMP System PMIX Hub Server Illinois PMP Illinois PMP System

PMIX Status/Plans May 2007 - Demonstrated a pilot point-topoint exchange of PMP information between California and Nevada September 2009 Demonstrated test data request and response through PMIX Hub Implement PMP data sharing pilot between KY and OH PMPs by December 2010.

PMIX Technology Advantages One web interface to PMIX hub instead of interfaces with each state data sharing partner Use of standards d to simplify PMIX implementation Justice Reference Architecture (JRA) National Information Exchange Model (NIEM) Available work products to support development

Statutory authority HIPAA Policy Challenges Allowable access to data User authentication Data security/data retention Usage and disclosure of data Who enforces?

David R. Hopkins KASPER Project Manager Kentucky Cabinet for Health and Family Services 275 East Main Street, 5ED Frankfort, KY 40621 502-564-2815 ext. 3162 Dave.Hopkins@ky.gov